Left atrial appendage closure for stroke prevention emerging technologies

Faisal F. Syed, Paul Andrew Friedman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Current anticoagulant therapies aimed at stroke prevention in atrial fibrillation (AF) are increasingly challenged by a complex patient population at significant risk of bleeding. Mounting evidence shows that left atrial appendage (LAA) closure is an effective strategy for reducing stroke risk in patients with nonvalvular AF, without the need for anticoagulation. Several approaches and devices have been developed in recent years, each with their own set of advantages and disadvantages. This article reviews these approaches, identifies pertinent aspects, and outlines necessary or ongoing research in establishing LAA closure as a safe and effective approach to stroke risk reduction.

Original languageEnglish (US)
Pages (from-to)141-160
Number of pages20
JournalCardiac Electrophysiology Clinics
Volume6
Issue number1
DOIs
StatePublished - Mar 2014

Fingerprint

Atrial Appendage
Stroke
Technology
Atrial Fibrillation
Risk Reduction Behavior
Anticoagulants
Hemorrhage
Equipment and Supplies
Research
Therapeutics

Keywords

  • Atrial fibrillation
  • Cardioembolic risk
  • Left atrial appendage closure
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Left atrial appendage closure for stroke prevention emerging technologies. / Syed, Faisal F.; Friedman, Paul Andrew.

In: Cardiac Electrophysiology Clinics, Vol. 6, No. 1, 03.2014, p. 141-160.

Research output: Contribution to journalArticle

@article{89741809d4a641728d48d578852174e7,
title = "Left atrial appendage closure for stroke prevention emerging technologies",
abstract = "Current anticoagulant therapies aimed at stroke prevention in atrial fibrillation (AF) are increasingly challenged by a complex patient population at significant risk of bleeding. Mounting evidence shows that left atrial appendage (LAA) closure is an effective strategy for reducing stroke risk in patients with nonvalvular AF, without the need for anticoagulation. Several approaches and devices have been developed in recent years, each with their own set of advantages and disadvantages. This article reviews these approaches, identifies pertinent aspects, and outlines necessary or ongoing research in establishing LAA closure as a safe and effective approach to stroke risk reduction.",
keywords = "Atrial fibrillation, Cardioembolic risk, Left atrial appendage closure, Stroke",
author = "Syed, {Faisal F.} and Friedman, {Paul Andrew}",
year = "2014",
month = "3",
doi = "10.1016/j.ccep.2013.12.002",
language = "English (US)",
volume = "6",
pages = "141--160",
journal = "Cardiac Electrophysiology Clinics",
issn = "1877-9182",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Left atrial appendage closure for stroke prevention emerging technologies

AU - Syed, Faisal F.

AU - Friedman, Paul Andrew

PY - 2014/3

Y1 - 2014/3

N2 - Current anticoagulant therapies aimed at stroke prevention in atrial fibrillation (AF) are increasingly challenged by a complex patient population at significant risk of bleeding. Mounting evidence shows that left atrial appendage (LAA) closure is an effective strategy for reducing stroke risk in patients with nonvalvular AF, without the need for anticoagulation. Several approaches and devices have been developed in recent years, each with their own set of advantages and disadvantages. This article reviews these approaches, identifies pertinent aspects, and outlines necessary or ongoing research in establishing LAA closure as a safe and effective approach to stroke risk reduction.

AB - Current anticoagulant therapies aimed at stroke prevention in atrial fibrillation (AF) are increasingly challenged by a complex patient population at significant risk of bleeding. Mounting evidence shows that left atrial appendage (LAA) closure is an effective strategy for reducing stroke risk in patients with nonvalvular AF, without the need for anticoagulation. Several approaches and devices have been developed in recent years, each with their own set of advantages and disadvantages. This article reviews these approaches, identifies pertinent aspects, and outlines necessary or ongoing research in establishing LAA closure as a safe and effective approach to stroke risk reduction.

KW - Atrial fibrillation

KW - Cardioembolic risk

KW - Left atrial appendage closure

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84893420998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893420998&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2013.12.002

DO - 10.1016/j.ccep.2013.12.002

M3 - Article

AN - SCOPUS:84893420998

VL - 6

SP - 141

EP - 160

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

SN - 1877-9182

IS - 1

ER -